“…Abnormal amyloid aggregation of a variety of proteins, such as amyloid-β (Aβ), Tau, α-synuclein (α-syn), and TDP-43 is closely associated with the initiation and progression of different neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). − Mounting evidence has shown that amyloid fibrils serve as the key pathological entities with a wide range of distinct pathological activities, including neuron-to-neuron transmission and propagation, , disruption of protein quality control, , induction of neuroinflammation, and cell death. , Over the past two decades, structures of different amyloid fibrils have been intensively investigated by solid-state NMR (ssNMR) and cryo-electron microscopy (cryo-EM). − Most amyloid proteins employ a portion of their sequences to form a rigid fibril core (FC), while leaving the rest, usually terminal sequences (referred to as terminal regions, TRs) disordered and coating on the surface of the FC . Many studies have shown that the FC represents the polymorphic structures and the overall physiochemical properties of the fibrils, including stability, stiffness, and seeding capability. ,, In contrast, the TRs play an important role in mediating the interaction between amyloid fibril and different binding proteins, including receptors, − chaperones, − and proteasome, to fulfill various pathological activities.…”